173 related articles for article (PubMed ID: 15796959)
21. Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients.
Thorstensen L; Qvist H; Heim S; Liefers GJ; Nesland JM; Giercksky KE; Lothe RA
Neoplasia; 2000; 2(6):514-22. PubMed ID: 11228544
[TBL] [Abstract][Full Text] [Related]
22. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
23. [Study of loss of heterozygosity in oligodendroglial tumors by real-time quantitative polymerase chain reaction-based microsatellite analysis].
Zhang SK; Lu DH; Piao YS; Cai YN; Xu QZ
Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):731-4. PubMed ID: 17374257
[TBL] [Abstract][Full Text] [Related]
24. Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis.
Bahrami S; Cheng L; Wang M; Jones TD; Malone JC; Billings SD
Mod Pathol; 2007 Aug; 20(8):821-7. PubMed ID: 17571079
[TBL] [Abstract][Full Text] [Related]
25. Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.
Dacic S; Finkelstein SD; Yousem SA
Exp Mol Pathol; 2005 Apr; 78(2):135-9. PubMed ID: 15713439
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart.
Mancini I; Righi A; Gambarotti M; Picci P; Dei Tos AP; Billings SD; Simi L; Franchi A
Histopathology; 2017 Sep; 71(3):453-460. PubMed ID: 28477388
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
28. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer.
Hu N; Roth MJ; Emmert-Buck MR; Tang ZZ; Polymeropolous M; Wang QH; Goldstein AM; Han XY; Dawsey SM; Ding T; Giffen C; Taylor PR
Clin Cancer Res; 1999 Nov; 5(11):3476-82. PubMed ID: 10589761
[TBL] [Abstract][Full Text] [Related]
29. Genotypic analysis of pulmonary Langerhans cell histiocytosis.
Dacic S; Trusky C; Bakker A; Finkelstein SD; Yousem SA
Hum Pathol; 2003 Dec; 34(12):1345-9. PubMed ID: 14691922
[TBL] [Abstract][Full Text] [Related]
30. [Loss of heterozygosity of chromosome 1p/19q and p53 protein expression in oligodendroglioma].
Xiong J; Liu Y; Li C; Zhu JJ; Ye ZR; Mao Y; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):445-50. PubMed ID: 19781190
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
Bigner SH; Matthews MR; Rasheed BK; Wiltshire RN; Friedman HS; Friedman AH; Stenzel TT; Dawes DM; McLendon RE; Bigner DD
Am J Pathol; 1999 Aug; 155(2):375-86. PubMed ID: 10433931
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity at 1p, 8p, 10p, 13q, and 17p in advanced urothelial cancer and lack of relation to chemotherapy response and outcome.
Sengeløv L; Christensen M; von der Maase HD; Horn T; Marcussen N; Kamby C; Orntoft T
Cancer Genet Cytogenet; 2000 Dec; 123(2):109-13. PubMed ID: 11156735
[TBL] [Abstract][Full Text] [Related]
33. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
34. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
35. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
Xu XF; Gao YN; Cheng SJ
Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
[TBL] [Abstract][Full Text] [Related]
36. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder.
Cheng L; MacLennan GT; Zhang S; Wang M; Pan CX; Koch MO
Cancer; 2004 Jul; 101(1):183-8. PubMed ID: 15222005
[TBL] [Abstract][Full Text] [Related]
37. Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?
Gadji M; Fortin D; Tsanaclis AM; Drouin R
Cancer Genet Cytogenet; 2009 Oct; 194(1):12-22. PubMed ID: 19737649
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.
Grundei T; Vogelsang H; Ott K; Mueller J; Scholz M; Becker K; Fink U; Siewert JR; Höfler H; Keller G
Clin Cancer Res; 2000 Dec; 6(12):4782-8. PubMed ID: 11156235
[TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma.
Okuno T; Ueda M; Tsuruyama T; Haga H; Takada Y; Maetani Y; Tamaki K; Manabe T; Tanaka K; Uemoto S
Cancer Sci; 2009 Mar; 100(3):520-8. PubMed ID: 19077004
[TBL] [Abstract][Full Text] [Related]
40. Identification of differentially expressed genes and their subpathways in recurrent versus primary bone giant cell tumors.
Chen S; Li C; Wu B; Zhang C; Liu C; Lin X; Wu X; Sun L; Liu C; Chen B; Zhong Z; Xu L; Li E
Int J Oncol; 2014 Sep; 45(3):1133-42. PubMed ID: 24969034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
